首页> 外文期刊>British Medical Journal >Vitamin K and childhood cancer: a population based case-control study in Lower Saxony, Germany
【24h】

Vitamin K and childhood cancer: a population based case-control study in Lower Saxony, Germany

机译:维生素K与儿童癌症:德国下萨克森州的一项基于人群的病例对照研究

获取原文
获取原文并翻译 | 示例
       

摘要

Objective—To confirm or refute a possible association of parenteral vitamin K prophylaxis and childhood cancer. Design—Population based case-control study. Comparison of vitamin K exposure in children with leukaemia or other common tumours with two control groups. Setting—State of Lower Saxony (north western part of Germany); case recruitment from the German childhood cancer registry. Subjects—272 children with leukaemia, nephroblastoma, neuroblastoma, rhabdomyo-sarcoma, and tumours of the central nervous system diagnosed between 1 July 1988 and 30 June 1993; children were aged between 30 days and 15 years at diagnosis. 334 population based controls without diagnoses of cancer matched to the leukaemia cases for age and sex. Main exposure measures—Parenteral vitamin K prophylaxis (intramuscular and subcutaneous) versus oral and no vitamin K prophylaxis. Results—An association between parenteral vitamin K exposure and childhood cancer (leukaemias and other tumours combined) could not be confirmed (odds ratio 1.04, 95% confidence interval 0.74 to 1.48). For leukaemias the observed odds ratio was only 0.98 (0.64 to 1.50) (comparison of leukaemia cases with local controls 1.24 (0.68 to 2.25); state controls 0.82 (0.50 to 1.36)). These odds ratios remained almost unchanged when several potential confounders were considered in the logistic regression model. Conclusions—This population based study adds substantial evidence that there is no association between parenteral vitamin K and childhood cancer.
机译:目的—确认或驳斥肠胃外维生素K预防与儿童癌症的可能联系。设计-基于人群的病例对照研究。两个对照组患白血病或其他常见肿瘤的儿童中维生素K暴露的比较。设置-下萨克森州(德国西北部);德国儿童癌症登记处的病例招募。受试者:1988年7月1日至1993年6月30日之间确诊的272名患有白血病,肾母细胞瘤,神经母细胞瘤,横纹肌肉瘤和中枢神经系统肿瘤的儿童;诊断时儿童年龄在30天到15岁之间。 334名没有癌症诊断依据的人群对照与年龄和性别的白血病病例相符。主要接触措施-预防口服肠胃外维生素K(肌肉内和皮下)与口服预防维生素K。结果—肠胃外维生素K暴露与儿童期癌症(白血病和其他肿瘤合并)之间没有关联(赔率比1.04,95%置信区间0.74至1.48)。对于白血病,观察到的优势比仅为0.98(0.64至1.50)(与本地对照组为1.24(0.68至2.25)的白血病病例进行比较;国家对照组为0.82(0.50至1.36))。当在逻辑回归模型中考虑了几个潜在的混杂因素时,这些几率几乎保持不变。结论:这项基于人群的研究提供了大量证据,证明肠胃外维生素K与儿童癌症之间没有关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号